Driving Health Innovation Across Africa: i3’s Transformational Journey
Since its launch in June 2022, the Investing in Innovation Africa (i3) program has been dedicated to bridging the gap between African health tech innovators and major health purchasers. Through strategic partnerships and tailored support, i3 has empowered startups to scale their solutions, addressing critical supply chain challenges and improving healthcare delivery across the continent.
The program’s impact is already profound. With a focus on diversity and inclusion, particularly supporting women-led and Francophone companies, i3’s 3-pronged approach—risk-tolerant funding, market access, and development support—has enabled innovators to grow. By the conclusion of Phase 1 in May 2024, i3 had facilitated more than 450 bespoke connections between startups and customers, raised over $50 million for innovators, and created nearly 1,000 jobs, 45% of which were filled by women. These efforts directly reached 15 million people and helped deliver 250 million health products through 72,000 healthcare providers.
As i3 prepares for its next phase, the program continues to focus on scaling health tech innovations through improved partnerships, bespoke support, and access to finance that meet the unique needs of African innovators. By facilitating these key connections, i3 remains committed to shaping a healthier, more equitable future for the continent.
i3's 2nd Cohort Progress Update: Creating jobs, Reaching millions of Patients, and Expanding Geographically
We are excited to share the latest insights and achievements from Year 2 of the i3 program!
The innovators in the second cohort have gained significant traction over the last four months of the program and are improving access for an estimated 83m patients annually through at least 58k providers they serve.
Collectively, they have successfully secured an additional $11.3 million in funding, marking a significant milestone. On the front of job creation, 300 new jobs were created - notably 36% of these roles were filled by women, underscoring our commitment to women inclusion.
Lastly, we are excited to highlight the expansion efforts of 13 of our cohort members, both nationally and internationally. Innovators have also secured 45 partnerships, with five directly attributed to the i3 program. Here's a snapshot of our progress.
As we progress, we are finding that connecting innovators with potential customers/partners requires dynamic approaches thus prompting us to explore new strategies in our program delivery to facilitate more partnerships.
We are excited for the journey ahead and the lasting impact we will make with the innovators!
Until next quarter!
Celebrating Women-Led Innovators: Empowering change on International Women's Day
We join the world today to celebrate the International Women’s Day and spotlight the remarkable contributions of all 22 women-led companies among the 60 companies that has ever been enrolled on the Investing in Innovation (i3) program. I3 is creating a more inclusive ecosystem that embraces inclusion of women founders and unlocks the full potential of Africa's innovation landscape. For us, 'women-led' denotes a company where a woman holds shares, is integral to the management team, and actively participates in the day-to-day decision-making processes.
Women-led companies within the cohort leverage their technology to provide a range of services, including cloud-based inventory management and marketplace solutions for pharmacies, decentralized healthcare through teleconsultations and medication deliveries, offline and online dispensing and logistics for pharmacies, as well as equipping health workers with equipment, consumables, and online training, among others.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.